NY-ESO-1 expression and its serum immunoreactivity in esophageal cancer

By Akcakanat Argun   Kanda Tatsuo   Koyama Yu   Watanabe Michitoshi   Kimura Eiji   Yoshida Yutaka   Komukai Shintarou   Nakagawa Satoru   Odani Shoji   Fujii Hiroshi   Hatakeyama Katsuyoshi  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 1, 2004-07 ,pp. : 95-100

Springer Publishing Company

Access to resources Recommend Favorite

High TSC22D3 and low GBP1 expression in the liver is a risk factor for early recurrence of hepatocellular carcinoma

By                          

Experimental and Therapeutic Medicine, Vol. 2, Iss. 3, 2011-01 ,pp. : 425-431

Spandidos Publications

Access to resources Recommend Favorite

CA9 gene expression in conventional renal cell carcinoma: a potential marker for prediction of early metastasis after nephrectomy

By Li Guorong   Feng Gang   Gentil-Perret Anne   Genin Christian   Tostain Jacques  

Clinical and Experimental Metastasis, Vol. 24, Iss. 3, 2007-05 ,pp. : 149-155

Springer Publishing Company

Access to resources Recommend Favorite

Mediator of DNA damage checkpoint protein 1 (MDC1) expression as a prognostic marker for nodal recurrence in early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy

By Patel Akshar  

Breast Cancer Research and Treatment, Vol. 126, Iss. 3, 2011-04 ,pp. : 601-607

Springer Publishing Company

Access to resources Recommend Favorite

A Gene Expression Profile for Vascular Invasion can Predict the Recurrence After Resection of Hepatocellular Carcinoma: a Microarray Approach

By Ho Ming-Chih   Lin Jen-Jen   Chen Chiung-Nien   Chen Chaur-Chin   Lee Hsinyu   Yang Ching-Yao   Ni Yen-Hsuan   Chang King-Jen   Hsu Hey-Chi   Hsieh Fon-Jou   Lee Po-Huang  

Annals of Surgical Oncology, Vol. 13, Iss. 11, 2006-11 ,pp. : 1474-1484

Springer Publishing Company

Access to resources Recommend Favorite